Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Preferred Stock Liabilities: 2020-2021

Historic Preferred Stock Liabilities for Prime Medicine (PRME) over the last 2 years, with Dec 2021 value amounting to $395.8 million.

  • Prime Medicine's Preferred Stock Liabilities rose 98.25% to $395.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $395.8 million, marking a year-over-year increase of 98.25%. This contributed to the annual value of $395.8 million for FY2021, which is 1171.20% up from last year.
  • As of FY2021, Prime Medicine's Preferred Stock Liabilities stood at $395.8 million, which was up 1,171.20% from $31.1 million recorded in FY2020.
  • In the past 5 years, Prime Medicine's Preferred Stock Liabilities ranged from a high of $395.8 million in FY2021 and a low of $31.1 million during FY2020.
  • Moreover, its 2-year median value for Preferred Stock Liabilities was $213.5 million (2020), whereas its average is $213.5 million.
  • Data for Prime Medicine's Preferred Stock Liabilities shows a peak YoY spiked of 1,171.20% (in 2021) over the last 5 years.
  • Over the past 2 years, Prime Medicine's Preferred Stock Liabilities (Yearly) stood at $31.1 million in 2020, then soared by 1,171.20% to $395.8 million in 2021.